Venturi Mask Market Analysis

Application (COPD, Asthma, Pneumonia, Myocardial Infarction, Respiratory Distress Syndrome)

The COPD segment is estimated to hold around 40% share of the global Venturi Mask Market in the coming years owing to the growing consumption of cigarettes. The fifth leading cause of death globally is COPD which is typically brought on by cigarette smoking, since it contains a lot of hazardous compounds, and can lead to several abnormalities in the trachea, lung tissue, and pulmonary blood vessels. For a patient with COPD, where it's crucial to avoid over-oxygenating the patient, the Venturi mask is considered an ideal option since they reduce the risk of carbon dioxide retention with the partial pressure of oxygen (PO2) titration.

For instance, the annual consumption of cigarettes is over 4 trillion, which results in more than 6 million deaths and about US 1 trillion in economic losses.

End-User (Hospitals and clinics, Homecare, ASCs)

The homecare segment is set to garner a notable share of 39% shortly. After being released from the hospital, oxygen therapy is frequently still required for patients with chronic pulmonary disorders, and to deliver a controlled oxygen flow venturi masks are used which is set by healthcare professional to ensure correct oxygen delivery and avoid other complications.

Our in-depth analysis of the global market includes the following segments: